Preclinical experiences with magnetic drug targeting: Tolerance and efficacy

Cancer Research

Volumn 56, Issue 20, 1996, Pages 4694-4701

  Lübbe, Andreas Stephan ^a,c   Bergemann, Christian ^a   Huhnt, Winfried ^a   Fricke, Thomas ^a   Riess, Hanno ^a   Brock, Jeffery Walter ^b   Huhn, Dieter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b MURRAY STATE UNIVERSITY   (United States)

^c Cecilien Klinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIRUBICIN;

ANIMAL EXPERIMENT; ARTICLE; CANCER CHEMOTHERAPY; COLON CARCINOMA; DRUG TARGETING; MAGNETIC FIELD; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DRUG DELIVERY SYSTEMS; EMBOLIZATION, THERAPEUTIC; EPIRUBICIN; MAGNETICS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0029796868     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Poste, G., and Kirsh, R. Site specific (targeted) drug delivery in cancer therapy. Biotechnology, 10: 869-885, 1983
2. Gurney, H., Dodwell, D., Thatcher, N , and Tattersall, M. H. N. Escalating drug delivery in cancer chemotherapy: a review of concepts and practice - part 1. Ann. Oncol., 4: 23-34, 1993.
3. Gupta, P. K. Drug targeting in chemotherapy a clinical perspective J. Pharm. Sci., 79: 949-962, 1990.
4. Gottstein, C., Winkler, U., Bohlen, H., Diehl, V., and Emgert, A. Immunotoxins: is there a clinical value? Ann. Oncol., 5: 97-103, 1994.
5. Siegall, C. B. Targeted toxins as anticancer agents. Cancer (Phila.), 74: 1006-1012, 1994
6. Gregoriadis, G., and Florence, A T. Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential. Drugs, 45 15-28, 1993.
7. Gabizon, A . Isacson, R , Libson, E., Kaufmann, B., Uziely, B., Catane, R., Ben-Dor, C. G., Rabello, E , Cass, P , and Peretz, T. Clinical studies of liposome-encapsulated doxorubicin. Acta Oncol., 33: 779-786, 1994.
8. Gupta, P. K., and Hung, C. T Magnetically controlled targeted chemotherapy In: N. Willmott and J. Daly (eds.), Microspheres and Regional Cancer Therapy, pp 1-59. Boca Raton, FL: CRC Press, Inc., 1993.
9. Widder, K J., Senyei, A. E , and Scarpelli, D. G. Magnetic microspheres: a model system for site specific drug delivery in vivo. Proc. Soc Exp. Biol. Med , 58: 141-146, 1978.
10. Widder, K. J., Morris, R. M., Poore, G. A., Howards, D P., and Senyei, A. E. Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats. Eur. J. Cancer Clin. Oncol., 19: 135-139, 1983.
11. Huhnt, W., and Lubbe, A S. Growth, microvessel density and tumour cell invasion of human colon adenocarcinoma under repeated treatment with hyperthermia and serotonin. J Cancer Res. Clin. Oncol., 121: 423-428, 1995
12. Lübbe, A. S., and Huhnt, W. Microvessel diameter of human colon adenocarcinoma during acute treatment with serotonin. Int. J. Microcirc. Clin. Exp., 14: 218-225, 1994.
13. Ferrucci, J T., and Stark, D. D. Iron oxide-enhanced MR imaging of the liver and spleen review of the first 5 years. AJR Am. J. Roentgenol., 155: 943-950, 1990.
14. Bacon, B. R., Stark, D D., Park, C H., Saini, S., Groman, E. V., Hahn, P. F., Compton, C. C., and Ferrucci, J. T. Ferrite particles: a new magnetic resonance imaging contrast agent Lack of acute or chronic hepatotoxicity after intravenous administration. J. Lab Clin. Med., 110: 164-171, 1987.
15. Weisleder, R , Stark, D. D , Engelstad, B. L., Bacon, B. R., Compton, C. C., White, D L., Jacobs, P., and Lewis, J. Superparamagnetic iron oxide pharmacokinetics and toxicity. AJR Am. J Roentgenol., 152: 167-173, 1989.
16. Van Hecke, P., Marchal, G., Decrop, E., and Baert, A. L Experimental study of the pharmacokinetics and dose response of ferrite particles used as contrast agent in MRI of the normal liver of the rabbit. Invest Radiol , 24: 397-399, 1989.
17. Plosker, G. L , and Faulds, D. Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy Drugs, 45: 788-856, 1983.
18. Bonadonna, G., Gianni, L., Santora, A, Bonfante, V., Bidoli, P., Casali, P., Demichelis, R., and Valagussa, P Drugs ten years later: epirubicin. Ann. Oncol., 4: 359-369, 1993.
19. Lübbe, A. S. Doxorubicin and local hyperthermia in the microcirculation of skeletal muscle. Cancer Chemother. Pharmacol., 31: 295-300, 1993.
20. Casazza, A. M., and Giuliani, F. S Preclinical properties of epirubicin In: G. Bonadonna (ed), Advances in Anthracycline Chemotherapy Epirubicin, pp. 31-40. Milan, Italy. Masson Italia Editori S.r 1, 1984.
21. Mosso, J. A , and Rand, R. W. Ferromagnetic silicone vascular occlusion, a technique for selective infarction of tumors and organs. Ann. Surg., 178: 663-668, 1973.
22. Giebel, W , Wagner, H., and Scheibe, F. Preliminary electrophysiological data after the obliteration of cochlear blood vessels by the action of a magnetic field on circulating iron particles Arch. Otorhinolaryngol , 242. 337-341, 1985
23. Meyers, P H., Cronic, F., and Nice, C. M. Experimental approach in the use and magnetic control of metallic iron particles in the lymphatic and vascular system of dogs as a contrast and isotopic agent. Am J Radiol., 90 1068-1077, 1963.
24. Nakamura, T , Konno, K., and Morone, T. Magneto-medicine: biological aspects of ferromagnetic fine particles. J Appl Physiol , 42 1320-1324, 1971.
25. Widder, K J , Senyei, A. E., and Ranney D. F. Magnetically responsive microspheres and other carriers for the biophysical targeting of antitumor agents. In: S. Gavattini, A. Goldin, F Howking, I. J Kopin, and R. J. Schnitzer (eds), Advances in Pharmacology and Chemotherapy, pp 213-239 New York Academic Press, 1979